Bilateral talks between government officials, insurers, and hospital bodies sought to reduce premium inflation and strengthen claims processing through the National Health Claims Exchange (NHCX)
India’s healthcare financing ecosystem is at a critical crossroads. The growing rift between health insurers and hospitals—manifested in disagreements over package rates, reimbursement timelines, cashless access, fraud detection, and medical inflation—has begun to directly impact millions of policyholders. Recent moves by the Insurance Regulatory and Development Authority of India (IRDAI), including consultations with the Confederation of Indian Industry (CII), mark an urgent attempt to bring systemic stability. This friction is neither entirely new nor unique to India; it mirrors structural challenges that countries globally have faced in balancing cost efficiency, quality of care, and private-sector incentives.
As India charts its long-term path, lessons from global healthcare systems—ranging from the UK’s fully public National Health Service (NHS) to the regulated private insurance-based models in Germany, Singapore, and the United States—offer critical insights into the pros, cons, and financial mechanics of running a sustainable healthcare economy.
Why the IRDAI stepped in: The flashpoints
Over the past year, disagreements between insurers and healthcare providers have intensified. IRDAI chairman Ajay Seth’s meeting with CII members signaled an important shift toward structured, moderated negotiations. While earlier bilateral talks between government officials, insurers, and hospital bodies sought to reduce premium inflation and strengthen claims processing through the National Health Claims Exchange (NHCX), these efforts produced limited consensus.
Insurers’ Concerns
- Medical inflation: India’s medical inflation hovered between 10–14% in recent years—among the highest in Asia, according to a Mercer Marsh Benefits report (2024).
- Unpredictable billing patterns: Insurers cite wide variation in hospital package pricing, leading to claim ratio volatility. Many companies report loss ratios touching 95–110% in retail health portfolios.
- Fraudulent claims: Estimates by IRDAI and industry data suggest that 5–8% of claims show patterns of abuse or fraud, creating pricing distortion.
Hospitals’ Counterpoints
- Inadequate reimbursement rates: Private hospitals argue that older package rates do not reflect the increase in wage bills, technology investments, and consumable costs.
- Payment delays: Delayed reimbursements from insurers and government schemes strain cash flows—critical for smaller hospitals.
- Unilateral deductions: Hospitals frequently call out insurers for arbitrary reductions without clinical justification.
These disputes have already caused real disruptions. The Association of Healthcare Providers India, representing over 15,000 hospitals, threatened suspension of cashless services. In Haryana, hospitals paused care for Ayushman Bharat beneficiaries due to ₹490 crore in pending dues. The lack of coordination between state welfare schemes, private insurers, and empanelled hospitals has made the problem systemic.
Comparing global healthcare models: what india can learn
India’s challenge lies in balancing public health goals with the realities of a large private-sector-dominated delivery system. Global models demonstrate how this balance can be achieved—or destabilized—depending on structures of ownership, funding, and regulation.
1. Fully government-owned and government-run systems
Examples:
- United Kingdom (NHS)
- Canada
- Nordic countries (Sweden, Norway, Denmark)
Pros
- Universal access based on need, not ability to pay.
- Government negotiation power helps control costs for drugs, devices, and procedures.
- Integrated systems reduce administrative overhead.
- Public trust remains high—UK’s NHS is among the most trusted institutions (Ipsos Survey 2024).
Cons
- Funding pressures lead to waiting times, staff shortages, and delayed procedures.
- Budget dependence makes systems vulnerable to political cycles.
- Limited private-sector participation may reduce innovation in technologies or service models.
Financial Data:
The UK spends 10.3% of GDP on healthcare (OECD 2024). With nearly 80% of expenditure publicly funded, cost pressures have led to multi-year budget deficits in NHS trusts.
Relevance to India
India cannot shift to an NHS-like model due to:
- low public health expenditure (~2.1% of GDP, National Health Accounts 2024),
- dependence on private hospitals for over 60% of inpatient care, and
- vast population heterogeneity.
Still, India can adopt stronger price negotiation frameworks, more transparent costing models, and public subsidies for essential services, similar to NHS procurement.
2. Fully private-owned but heavily government-regulated models
Examples:
- Germany (Statutory Health Insurance – SHI)
- Switzerland
- Singapore (MediShield Life + private top-ups)
- Netherlands
These countries rely on private insurers and private providers, but governments regulate pricing, quality, claim transparency, and universal coverage.
Pros
- Competition drives better service quality.
- Strong regulation keeps premiums predictable.
- Risks are equalized across insurers (risk pooling), preventing denial of care.
- Digital claims and standardized package rates reduce disputes.
Cons
- Premiums can rise if regulation weakens—seen in Germany’s SHI premium rise to ~16% of wages in 2024.
- Administrative costs are higher due to complex multi-payer systems.
- Wealthier customers often opt for premium insurance, creating dual-track systems.
Financial Data
- Switzerland spends 11.3% of GDP on healthcare (OECD 2024).
- Singapore spends only 4.1% of GDP, showing that high-quality outcomes are possible with strong savings-based models and regulated insurance.
Relevance to India
India’s system already resembles a fragmented version of these models:
- private providers dominate,
- multiple insurers operate in a competitive market,
- government schemes cover lower-income households.
Yet India lacks the standardized pricing, digital claims pipelines, and robust risk equalization mechanisms seen in Germany or Singapore.
The middle path: What a hybrid model means for India
India’s future lies in a hybrid model—publicly funded basic coverage (Ayushman Bharat), private-sector-driven service delivery, and regulated insurance markets.
For this model to succeed, the following must be addressed:
1. Standardizing package rates based on scientific costing
Countries like Japan and Germany use Diagnosis-Related Groups (DRGs) to standardize reimbursement. DRGs consider:
- clinical complexity,
- length of stay,
- consumables,
- overheads.
India’s current package pricing under Ayushman Bharat and private insurance varies dramatically even within a city.
Consulting firm insights:
A KPMG healthcare costing report (2023) notes 30–70% variation in surgical package rates across Tier 1 hospitals due to non-standard costing practices. EY’s health insurance outlook suggests that India could reduce claim disputes by up to 45% with DRG adoption.
2. Digitising claims and making NHCX the backbone of the ecosystem
The National Health Claims Exchange (NHCX), if fully implemented, can:
- eliminate paperwork,
- reduce fraud through data analytics,
- enable real-time verification of procedures,
- introduce transparency in pricing and patient records.
Singapore’s MOH Holdings and Estonia’s e-health system demonstrate that national-level digitization transforms insurance adjudication.
3. Ensuring timely reimbursements and penalty mechanisms
Delayed payments create ripple effects:
- hospitals increase package rates to offset delays,
- insurers raise premiums to cover cash-flow stress,
- patients ultimately bear the cost.
Germany’s SHI mandates penalties for delayed payments. India could adopt similar statutory frameworks.
4. Addressing medical inflation through pooled procurement
Medical inflation in India is driven by:
- high consumable costs,
- imported medical devices,
- rising clinical salaries,
- increased chronic disease burden.
Government-led pooled procurement—like the Tamil Nadu Medical Services Corporation (TNMSC) model—has reduced drug costs by up to 40%. Scaling this at the national level can help private hospitals control input costs, reducing the need for higher reimbursements.
Stakeholder perspectives: What each side wants
Hospitals
- Updated package rates reflecting real costs
- Guaranteed payment timelines
- Transparent deduction rationale
- National adoption of DRG-based pricing
- Redressal mechanisms for disputes
Insurers
- Uniform billing norms
- Reduction in fraud and unnecessary procedures
- Standardized costing
- Real-time data to control medical inflation
- Predictable claims ratio environment
Government
- Premium stabilisation
- Reduction in public expenditure leakages
- Expansion of Ayushman Bharat coverage
- Minimizing policyholder grievances
Financial stakes: Why this conflict cannot continue
India’s health insurance market has grown from ₹17,000 crore in 2010 to over ₹90,000 crore in 2024 (IRDAI annual report). Premiums have risen by 15–20% annually in some segments. Meanwhile:
- Claim payouts increased from ₹43,000 crore (2019) to ₹78,000 crore (2024).
- Average hospitalization cost rose by 23% between 2019–2024, according to NITI Aayog.
- Private hospitals report EBIDTA margins of only 6–9%, lower than global averages of 12–14%, largely due to delayed payments and unpredictable reimbursements (Deloitte Healthcare Report 2024).
If unaddressed, the friction could cause:
- further premium hikes,
- reduced cashless network size,
- decrease in policyholder satisfaction,
- slower expansion of government schemes.
How India can build a sustainable, low-friction healthcare financing model
Drawing on global learnings and local realities, India can adopt a structured, long-term approach.
1. Adopt a Unified National DRG Framework
This reduces debates over package pricing and aligns reimbursements across public and private providers.
2. Make NHCX mandatory for all claims
A fully digital pipeline reduces fraud, improves audit trails, and cuts turnaround times.
3. Establish a Healthcare Pricing and Outcomes Authority
Similar to the UK’s NICE, this body can:
- benchmark procedure costs,
- evaluate clinical outcomes,
- set national reimbursement standards.
4. Introduce Risk Equalization Across Insurers
Germany and the Netherlands use this to prevent insurers from cherry-picking low-risk customers.
5. Incentivize Preventive Care
Chronic diseases account for over 60% of India’s healthcare burden (ICMR).
Insurers could offer reduced premiums for preventive screenings, lifestyle programs, and chronic disease management.
6. Strengthen Public Spending
Increasing government health expenditure from 2.1% to 3% of GDP is essential for:
- supporting public hospitals,
- subsidizing low-income families,
- reducing pressure on private insurers.
Navigating the future with collaboration and global lessons
India stands at a transformative moment. The friction between insurers and hospitals is a symptom of a deeper structural issue—an outdated, fragmented ecosystem struggling to keep up with rising medical costs and expanding coverage needs.
By drawing upon global models, capitalizing on digital health infrastructure, adopting scientific costing methods, and fostering collaborative negotiations, India can build a healthcare financing ecosystem that is efficient, equitable, and sustainable.
The IRDAI’s decision to involve neutral institutions like CII and FICCI may be the catalyst needed. A balanced model—one that protects policyholders, ensures fair returns for hospitals, and provides financial stability for insurers—can become India’s best pathway forward. With pragmatic reforms and global learning, India can create a system where disputes give way to cooperation, costs become predictable, and patients remain the centre of the healthcare universe.
FOOTNOTE: A study by Research & Analysis Wing of Insurance Foundation of India (a not for profit organization) believes that a Healthcare Regulator in India will never be a reality as large number of Ministries / Organizations are involved in the running of insurance. They are namely Health Ministry, Ayush Ministry, Ministry of Chemicals (for Pharma), Education Ministry, Ministry of Finance, SEBI (for IPOs), RBI (for funding), state governments (for acquiring subsidised land) Power Ministry (for deciding lowest power tariff vs highest power tariff). Environment Ministry, Ministry of Electronics (for regulating medical equipment research and development, manufacturing, pricing).
Insurance penetration in healthcare is very low. Insurers are hesitant to insure hospital equipment or even issuing group health policy for the employees of hospitals.
